FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4315702495> ?p ?o ?g. }

• W4315702495 endingPage "618" @default.
• W4315702495 startingPage "618" @default.
• W4315702495 abstract "Plerixafor is widely used as up-front treatment with G-CSF to enhance peripheral blood hematopoietic stem cell output in patients failing previous mobilizations. Less frequently, plerixafor is used to rescue an unsatisfactory mobilization following chemotherapy (CT) and G-CSF. This study investigates if pre-collection factors affect the CD34+ cell harvest in chemotherapy and G-CSF mobilizations rescued by plerixafor. Clinical and hematological data relative to patients, mobilization, and apheresis products were retrospectively examined. The outcome was completing a target cell dose ≥ 2 × 106 CD34+ cells/kg at first apheresis. The effect exerted on the outcome by patient- and disease-related factors was investigated by univariate and multivariate logistic regression analysis. The analysis included data from 42 patients affected by hematological (39 patients) and non-hematological malignancies (three patients). Twenty-nine patients (69%) attained the target cell dose at first apheresis. Twelve out of the remaining 13 patients received an additional plerixafor administration, and all accomplished the transplant dose at a second apheresis procedure. Day -1 CD34+ PB count (OR1.46, 95% CI 1.1-1.9, p = 0.008) and platelet count (OR1.0, 95% CI 1.0-1.0, p = 0.033) predicted the achievement of the target dose at first apheresis, independently of pre-mobilization CT, radiation therapy, and disease status at mobilization. At ROC curve analysis, the best cut-off value predicting the successful collection at first apheresis was 7.5/µL for Day -1 CD34+ cell count (AUC 0.830, 0.69 sensitivity, and 0.92 specificity) and 75 × 109/L for Day -1 platelet count (AUC = 0.736, 0.65 sensitivity and 0.85 specificity). In conclusion, on-demand plerixafor rescue allows a successful stem cell collection, irrespectively of disease type and status, prior CT lines, and radiation exposure. Pre-apheresis CD34+ cells and platelet count predict the need for one or two aphereses." @default.
• W4315702495 created "2023-01-12" @default.
• W4315702495 creator A5011470026 @default.
• W4315702495 creator A5031422334 @default.
• W4315702495 creator A5036387483 @default.
• W4315702495 creator A5037495700 @default.
• W4315702495 creator A5037591788 @default.
• W4315702495 creator A5041148264 @default.
• W4315702495 creator A5055143336 @default.
• W4315702495 creator A5072186999 @default.
• W4315702495 creator A5086842390 @default.
• W4315702495 creator A5087087615 @default.
• W4315702495 date "2023-01-12" @default.
• W4315702495 modified "2023-10-04" @default.
• W4315702495 title "Day -1 CD34+ Cells and Platelet Count Predict the Number of Apheresis in Poor-Mobilizer Patients Rescued by Plerixafor" @default.
• W4315702495 cites W1598879592 @default.
• W4315702495 cites W1881943990 @default.
• W4315702495 cites W1969078983 @default.
• W4315702495 cites W1999501108 @default.
• W4315702495 cites W2003914332 @default.
• W4315702495 cites W2009299193 @default.
• W4315702495 cites W2010365172 @default.
• W4315702495 cites W2018519445 @default.
• W4315702495 cites W2020806642 @default.
• W4315702495 cites W2025709882 @default.
• W4315702495 cites W2034794564 @default.
• W4315702495 cites W2044242415 @default.
• W4315702495 cites W2045801734 @default.
• W4315702495 cites W2055571804 @default.
• W4315702495 cites W2068219465 @default.
• W4315702495 cites W2078566370 @default.
• W4315702495 cites W2085269642 @default.
• W4315702495 cites W2092295085 @default.
• W4315702495 cites W2094846825 @default.
• W4315702495 cites W2121735943 @default.
• W4315702495 cites W2125887123 @default.
• W4315702495 cites W2133201432 @default.
• W4315702495 cites W2165088970 @default.
• W4315702495 cites W2170762893 @default.
• W4315702495 cites W2486629951 @default.
• W4315702495 cites W2621741324 @default.
• W4315702495 cites W2767901548 @default.
• W4315702495 cites W2783266427 @default.
• W4315702495 cites W2997058345 @default.
• W4315702495 cites W3005616312 @default.
• W4315702495 cites W3095698173 @default.
• W4315702495 cites W3096322282 @default.
• W4315702495 cites W3132424591 @default.
• W4315702495 cites W3138473479 @default.
• W4315702495 cites W3139776026 @default.
• W4315702495 cites W3172124846 @default.
• W4315702495 cites W3177223790 @default.
• W4315702495 cites W3177446754 @default.
• W4315702495 cites W3195841388 @default.
• W4315702495 cites W3205694180 @default.
• W4315702495 cites W3216118321 @default.
• W4315702495 cites W4200044279 @default.
• W4315702495 cites W4225150445 @default.
• W4315702495 doi "https://doi.org/10.3390/jcm12020618" @default.
• W4315702495 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36675546" @default.
• W4315702495 hasPublicationYear "2023" @default.
• W4315702495 type Work @default.
• W4315702495 citedByCount "0" @default.
• W4315702495 crossrefType "journal-article" @default.
• W4315702495 hasAuthorship W4315702495A5011470026 @default.
• W4315702495 hasAuthorship W4315702495A5031422334 @default.
• W4315702495 hasAuthorship W4315702495A5036387483 @default.
• W4315702495 hasAuthorship W4315702495A5037495700 @default.
• W4315702495 hasAuthorship W4315702495A5037591788 @default.
• W4315702495 hasAuthorship W4315702495A5041148264 @default.
• W4315702495 hasAuthorship W4315702495A5055143336 @default.
• W4315702495 hasAuthorship W4315702495A5072186999 @default.
• W4315702495 hasAuthorship W4315702495A5086842390 @default.
• W4315702495 hasAuthorship W4315702495A5087087615 @default.
• W4315702495 hasBestOaLocation W43157024951 @default.
• W4315702495 hasConcept C10205521 @default.
• W4315702495 hasConcept C126322002 @default.
• W4315702495 hasConcept C126894567 @default.
• W4315702495 hasConcept C129470790 @default.
• W4315702495 hasConcept C13373296 @default.
• W4315702495 hasConcept C141071460 @default.
• W4315702495 hasConcept C143998085 @default.
• W4315702495 hasConcept C144301174 @default.
• W4315702495 hasConcept C156708679 @default.
• W4315702495 hasConcept C166957645 @default.
• W4315702495 hasConcept C170493617 @default.
• W4315702495 hasConcept C2776694085 @default.
• W4315702495 hasConcept C2776738589 @default.
• W4315702495 hasConcept C2777408962 @default.
• W4315702495 hasConcept C2778828106 @default.
• W4315702495 hasConcept C28328180 @default.
• W4315702495 hasConcept C2911091166 @default.
• W4315702495 hasConcept C38180746 @default.
• W4315702495 hasConcept C54355233 @default.
• W4315702495 hasConcept C71924100 @default.
• W4315702495 hasConcept C86803240 @default.
• W4315702495 hasConcept C89560881 @default.
• W4315702495 hasConcept C90924648 @default.

• next